This page is no longer being updated. We are now EY Pythagoras. Follow the EY LinkedIn page here: https://www.linkedin.com/company/ernstandyoung/ to keep up to date with our news, events and technical consulting offerings. CRM, Microsoft Dynamics 365 Consultancy, training, support, SharePoint, SharePoint Consultancy, training, support, Office 365, Office 365 Consultancy, training, support, Yammer, Power BI, Microsoft Dynamics 365, Azure, Power Apps, and Power Platform

Sofinnova Partners is a leading European VC firm in life sciences, specializing in healthcare and sustainability. Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise. Sofinnova Partners is a hands-on company builder across the entire value chain of life sciences investments, from seed to later-stage. The firm actively partners with ambitious entrepreneurs as a lead or cornerstone investor to develop transformative innovations that have the potential …

We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare

Tags: CAC40 Sectors: Pharmaceutical

We actively fund innovative companies within the two evolving fields of Digital technologies and Life sciences. Seventure Partners is a long term equity investor that actively supports innovative companies aiming at generating positive impacts on Humankind, Society, Sustainability and the Planet. With €950m net commitments under management as of the end of 2022, Seventure is a leading venture capital firm in Europe investing since 1997 in innovative businesses with high growth potential in 2 main areas: Life sciences (Biotech, Health & digital Health, Nutrition, Foodtech, Blue Economy, Aquaculture, Animal & Agriculture, Sport & Wellness ...) with a specific interest for …

Sectors: Startup accelerator & VC

Nurturing our world and humankind by advancing care for animals The world’s leading animal health company. Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. We’ve been innovating ways to predict, prevent, detect, and treat animal illness for over 70 years, and we continue to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock farmers. Our leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. Community Guidelines: This page is intended for learning more about …

Sectors: Animal Health

We are uniting science, technology and talent to get ahead of disease together. Our community guidelines: https://gsk.to/socialmedia Pharmaceutical products and Vaccines

Sectors: Pharmaceutical

Visionary ventures IP Group accelerates the impact of science for a better future. As the most active UK based, early-stage science investor, we develop and support some of the world’s most exciting businesses in deeptech, life sciences and cleantech (led by Kiko Ventures). Through Parkwalk, the UK's largest growth EIS fund manager, we also back world-changing innovation emerging in leading universities and research institutions. Our specialist investment team combines sector expertise with an international approach. Together we have a strong track record of success, having backed high-profile companies including Oxford Nanopore Technologies plc, First Light Fusion, Hysata, and Oxbotica. IP …

Sustainability Through Innovation Founded in 2005, ETF Partners (The Environmental Technologies Fund) stands as Europe's original venture capital firm dedicated to sustainability and impact investing. For nearly twenty years we have established a leading position in promoting sustainability through innovation. ETF Partners is founded on the conviction that entrepreneurship and innovation are critical in addressing the global challenges presented by the climate crisis. We are committed to fostering and supporting Europe’s ecosystem of pioneering entrepreneurs who are creating the innovative solutions capable of making a profound environmental impact. We believe in the transformative power of aligning profit with purpose in …

Where tech meets nature. Astanor is a mission-driven, venture capital firm backing high impact agrifood tech solutions. Astanor - where tech meets nature - is an impact investor that backs ambitious entrepreneurs in Europe and beyond with disruptive, scalable solutions that will create systemic change across the agrifood value chain, from soil to gut. We partner with founders that are committed to restoring balance and sustainability to the land and oceans, prioritising nature and culture, nurturing change and feeding growth.

The leading media brand empowering startup Europe | Backed by the Financial Times. Sifted is the critical friend of the European startup ecosystem – providing startup founders, senior management teams, investors and service providers with the curated insights, in-depth analysis and networking opportunities they need to grow their business. Whatever your role is within the ecosystem, however you like to stay up to speed, we've got something for you: 🗞️ Sifted Daily: Our daily newsletter is the essential morning read for founders, investors and corporates who want a quick digest of the news that matters 🔎 Sifted Pro: Our premium …

Tech Nation is the leading growth platform empowering ambitious founders with the access & knowledge they need to scale Tech Nation fuels the growth of game-changing founders, leaders and scaling companies so they can positively transform societies and economies. We provide them with the coaching, community and connections they need for their journey in designing the future. Tech Nation - the growth platform for tech companies and leaders. Entrepreneurship, Digital, UK Tech, Tech ecosystem, Digital learning, Startups, Scaleups, Technology, Tech insights, UK Tech Visas, and Tech Reports

Building a world-leading innovation ecosystem with Oxford University at its heart. Oxford University Innovation Limited is wholly owned by the University of Oxford. The company mission is to be the leading international technology transfer organisation, to transfer technology and expertise from the University of Oxford, to deliver value to all our clients, and to maximise social and economic benefits in a commercial manner. Oxford University Innovation helps staff and students to apply their expertise and research for wider social and economic benefit. Our role is to help University staff and students bring the benefits of their research and expertise to …

Sectors: Research

Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki Cardiovascular, Immunology, Neuroscience, Solid Tumors, Hematology, Chemistry, xRNA, Radioligand, and Gene and cell therapy

Sectors: Pharmaceutical

Our mission is to deliver the greatest possible impact to people through mRNA medicines. At Moderna, we believe messenger RNA, or mRNA, is the “software of life.” Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease. Given its essential role, we believe mRNA could be used to create a new category of medicines with significant potential to improve the lives of patients. We are pioneering a new class of medicines made of messenger RNA, or mRNA. The potential implications of using …

Sectors: Biotechnology Pharmaceutical

A global financial advisory and asset management firm, built over generations on a foundation of client service Founded in 1848, Lazard is one of the world's preeminent financial advisory and asset management firms, with operations in North and South America, Europe, the Middle East, Asia, and Australia. Lazard provides advice on mergers and acquisitions, capital markets and capital solutions, restructuring and liability management, geopolitics, and other strategic matters, as well as asset management and investment solutions to institutions, corporations, governments, partnerships, family offices, and high net worth individuals. For more information, please visit www.lazard.com. Social Media Disclosure: https://www.lazard.com/social-media-community-guidelines/ Financial Advisory …

Sectors: Bank

Find and close deals with all-in-one prospecting solutions powered by the leader in private-company data. Crunchbase is the leading provider of private-company prospecting and research solutions. 75 million users—including salespeople, entrepreneurs, investors, and market researchers—use Crunchbase to prospect for new business opportunities. And companies all over the world rely on us to power their applications, making over 6 billion calls to our API each year.

Sectors: Media

Building a better world for everyone. Since it was established by Trinity College in 1970, the Cambridge Science Park has played a pivotal role in the “Cambridge Phenomenon” - the transformation of Cambridge from a market town with a world-class university to one of the hottest technology hotspots in the world. Today the 152-acre site is home to 100 science and technology companies ranging from spin-outs from the University of Cambridge to multinational companies seeking access to the brightest graduates and entrepreneurs from Cambridge’s diverse talent pool. Many are working on potentially life changing technologies from personalised medicines and non-invasive …

Sectors: Real Estate Startup accelerator & VC

Helping to commercialise research from the University of Cambridge for the benefit of society worldwide. Cambridge Enterprise is the commercialisation arm of the University of Cambridge. At Cambridge Enterprise, we help University of Cambridge members create beneficial impact from their research and expertise that can change the world, through academic consultancy, intellectual property management, development and licensing, venture building, venture funding and convening and connecting the wider Cambridge innovation ecosystem. Our success is measured in the success of our University partners as they bring their work to market, be it ground-breaking stem cell research, critical suspension technology used in Formula …

Sectors: Startup accelerator & VC

Bringing it all together for today's investor Welcome to Aviva Investors. The global asset manager that chooses integration. The future is full of questions. Only by working closely with our clients can we find the answers. That’s why we integrate our whole business around our clients – their goals, their values and the experience they have when they work with us. That’s why we start by listening closely and understanding their investment aspirations and concerns – from low prospective investment returns, to highly correlated asset prices; from the prospect of rising global interest rates, to the challenges and opportunities of …

Sectors: Insurance

We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com. Community Guidelines: bit.ly/2MgAcio Pharmaceutical, Biopharmaceutical, Innovation, Research and development, and Global business

Sectors: Pharmaceutical

AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html. Biopharmaceutical, Biotechnology, Innovation, Research and Development, Manufacturing, Biotherapeutics, Oncology, Immunology, Virology, Neuroscience, Womens Health, Aesthetics, and Eye Care

Sectors: Pharmaceutical

Transforming Tomorrow Together UK Research and Innovation (UKRI) is the public sector organisation that invests £8 billion annually to support the entire research and innovation system. We strive for a society powered and empowered by research and innovation, with economic, social, environmental and cultural benefits for all. We invest in people, places, ideas, innovation and impacts, empowering researchers, innovators and entrepreneurs to turn the many challenges we all face into opportunities, driving up prosperity and wellbeing across the UK and globally. The impacts of our work are felt right across society. We enrich lives by increasing our understanding of ourselves …

Sectors: Public business cluster

This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trademark MERCK in the U.S. and Canada. _______________________________ We are Merck, a leading global science and technology company headquartered in Germany. We are curious explorers, courageous pioneers, and ingenious inventors. Our colleagues across the globe love innovating with science and technology to enrich people’s lives with our solutions in Life Science, Healthcare, …

Tags: DAX30 Sectors: Biotechnology Pharmaceutical

At PwC, our purpose is to build trust in society and solve important problems. We’re a network of firms in 152 countries with over 327,000 people who are committed to delivering quality in assurance, advisory and tax services. Find out more and tell us what matters to you by visiting us at www.pwc.com. PwC refers to the PwC network and/or one or more of its member firms, each of which is a separate legal entity. Content on this page has been prepared for general information only and is not intended to be relied upon as accounting, tax or professional advice. …

Sectors: Consulting, audit

Transatlantic venture capital investor seeking to create lasting success for rapidly scaling entrepreneurial companies Beringea is a venture capital firm empowering entrepreneurs across the U.S., U.K., and Europe to build great businesses. With offices in Detroit and London and over $715 million under management in the United States and United Kingdom, we provide patient capital and a global footprint to back founders throughout their journey, helping them overcome barriers to scale and build international success stories. Our track record of three decades of successful investing across every major industry has inspired our own entrepreneurial ethos; cultivated an exceptional network throughout …

Sectors: Startup accelerator & VC

About the Financial Times The Financial Times is one of the world’s leading business news organisations, recognised internationally for its authority, integrity and accuracy. The FT has a record paying readership of one million, three-quarters of which are digital subscriptions. It is part of Nikkei Inc., which provides a broad range of information, news and services for the global business community. Learn more about the FT, including announcements and career opportunities, at aboutus.ft.com. Subscribe at subs.ft.com. One of the world’s leading business news organisations

Sectors: Media

EU-Startups.com is the leading online magazine about startups in Europe. Also check out our annual EU-Startups Summit! Menlo Media is the parent company of EU-Startups.com, the leading online publication about startups in Europe. In addition, Menlo Media organizes the annual EU-Startups Summit and focuses on FutureTravel.com and related projects.

Sectors: Media

Reimagining energy for people and our planet We believe the world wants and needs a better and more balanced energy system that delivers secure, affordable and lower-carbon energy. We're playing our part by investing in today's energy system, which is mainly oil and gas – and, not or – in our transition and the energy transition. While today we’re mostly in oil and gas, we increased the proportion of our global annual investment that went into our lower carbon & other transition businesses from around 3% in 2019 to around 23% in 2023. Increasing investment in these engines is a …

Sectors: Energy

EY exists to build a better working world, helping create long-term value for clients, people and society and build trust in the capital markets. Enabled by data and technology, diverse EY teams in over 150 countries provide trust through assurance and help clients grow, transform and operate. Working across assurance, consulting, law, strategy, tax and transactions, EY teams ask better questions to find new answers for the complex issues facing our world today. Find out more about the EY global network http://ey.com/en_gl/legal-statement Advisory, Assurance, Tax, Transactions, Audit, Mergers, M&A, Financial Services, Accounting, Professional Services, Law, Technology, Consulting, Data, Transformation, Strategy, …

Sectors: Consulting, audit

Delivering intelligent computing everywhere. Semiconductors, Wireless, Mobile, Networking, Wi-Fi, Small Cells, Wireless Power, Augmented Reality, Location Services, Internet of Things, Automotive, 5G, PC computing, and Bluetooth

Sectors: Semiconductors

The London Stock Exchange is at the heart of where ideas meet capital and become reality. Home to nearly 2,000 companies from over 100 countries, with a combined value of £4.8 trillion. Whether you’re a business seeking greater horizons, a government with an ambitious sustainability agenda, a pension fund seeking returns for your client, we provide the flexibility to make the connections you need to create real impact. We offer our customers extensive access to capital markets and liquidity across multiple asset classes. We operate a broad range of international equity, fixed income and exchange traded products. The London Stock …

Sectors: Finance

Teva Pharmaceuticals has been developing and producing medicines to help improve people’s lives for more than a century. We are committed to being a global leader in generic and specialty medicines with a portfolio of 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day. They are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products. Learn more at www.tevapharm.com. Please …

Sectors: Pharmaceutical

We found, fund and build transformational businesses via our unique partnership with the University of Oxford Oxford Science Enterprises (OSE) is an independent, billion-pound investment company, created in 2015 to found, fund and build transformational businesses across specialist areas of life sciences, health tech, AI, new compute, climate tech and agtech. Via our unique partnership with the University of Oxford, the world's #1 research university, we turn the world's most advanced science and technology into companies tackling the world's toughest challenges. In nine years, we have invested £0.7 billion in over 120 ambitious companies built on Oxford science. A key …

Sectors: Startup accelerator & VC